Pura Vida Investments, LLC Coherus Bio Sciences, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $816,499 - $1.07 Million	-50,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $964,894 - $1.38 Million	-59,196 Reduced 54.21%	50,000 $1.01 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $739,062 - $1.25 Million	-56,417 Reduced 34.07%	109,196 $2.41 Million
Q1 2019 May 14, 2019	SELL	$8.38 - $15.5 $380,938 - $704,599	-45,458 Reduced 21.54%	165,613 $2.26 Million
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $1.61 Million - $3.03 Million	186,071 Added 744.28%	211,071 $1.91 Million
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $208,750 - $360,000	25,000	25,000 $0

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.